🚀 VC round data is live in beta, check it out!
Sundrug Valuation Multiples
Discover revenue and EBITDA valuation multiples for Sundrug and similar public comparables like Fragua, DaShenLin Pharmaceutical, Ebos Group, COSMOS Pharmaceutical and more.
Sundrug Overview
About Sundrug
Sundrug Co Ltd is a Japanese-based company engaged in the operation of drug stores and discount stores. The Group operates through two segments: the Drug Store Business, which mainly sells pharmaceuticals, cosmetics, and daily necessities, and the Discount Store Business, which mainly sells food products, household goods, and other related items. It generates the majority of its revenue from the Drugstore business segment.
Founded
1965
HQ
Employees
16.5K
Website
Sectors
Financials (LTM)
EV
$3B
Sundrug Financials
Sundrug reported last 12-month revenue of $5B and EBITDA of $419M.
In the same LTM period, Sundrug generated $722M in gross profit, $419M in EBITDA, and $202M in net income.
Revenue (LTM)
Sundrug P&L
In the most recent fiscal year, Sundrug reported revenue of $5B and EBITDA of $426M.
Sundrug expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $5B | XXX | $5B | XXX | XXX | XXX |
| Gross Profit | $722M | XXX | $1B | XXX | XXX | XXX |
| Gross Margin | 14% | XXX | 23% | XXX | XXX | XXX |
| EBITDA | $419M | XXX | $426M | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| EBIT Margin | 6% | XXX | 6% | XXX | XXX | XXX |
| Net Profit | $202M | XXX | $211M | XXX | XXX | XXX |
| Net Margin | 4% | XXX | 4% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Sundrug Stock Performance
Sundrug has current market cap of $3B, and enterprise value of $3B.
Market Cap Evolution
Sundrug's stock price is $25.89.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $3B | -0.6% | XXX | XXX | XXX | $1.80 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSundrug Valuation Multiples
Sundrug trades at 0.5x EV/Revenue multiple, and 6.9x EV/EBITDA.
EV / Revenue (LTM)
Sundrug Financial Valuation Multiples
As of March 20, 2026, Sundrug has market cap of $3B and EV of $3B.
Equity research analysts estimate Sundrug's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Sundrug has a P/E ratio of 15.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV/Revenue | 0.5x | XXX | 0.5x | XXX | XXX | XXX |
| EV/EBITDA | 6.9x | XXX | 6.8x | XXX | XXX | XXX |
| EV/EBIT | 9.7x | XXX | 9.5x | XXX | XXX | XXX |
| EV/Gross Profit | 4.0x | XXX | 2.3x | XXX | XXX | XXX |
| P/E | 15.0x | XXX | 14.4x | XXX | XXX | XXX |
| EV/FCF | 40.6x | XXX | 67.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Sundrug Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Sundrug Margins & Growth Rates
Sundrug's revenue in the last 12 month grew by 8%.
Sundrug's revenue per employee in the last FY averaged $0.3M.
Sundrug's rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Sundrug's rule of X is 28% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Sundrug Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | (2%) | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | (2%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 16% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 28% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 18% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Sundrug Public Comps
See public comps and valuation multiples for other Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Fragua | XXX | XXX | XXX | XXX | XXX | XXX |
| DaShenLin Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| Ebos Group | XXX | XXX | XXX | XXX | XXX | XXX |
| COSMOS Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| Nahdi Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sundrug M&A Activity
Sundrug acquired XXX companies to date.
Last acquisition by Sundrug was on XXXXXXXX, XXXXX. Sundrug acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Sundrug
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSundrug Investment Activity
Sundrug invested in XXX companies to date.
Sundrug made its latest investment on XXXXXXXX, XXXXX. Sundrug invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Sundrug
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Sundrug
| When was Sundrug founded? | Sundrug was founded in 1965. |
| Where is Sundrug headquartered? | Sundrug is headquartered in Japan. |
| How many employees does Sundrug have? | As of today, Sundrug has over 16K employees. |
| Who is the CEO of Sundrug? | Sundrug's CEO is Hiroshi Sadakata. |
| Is Sundrug publicly listed? | Yes, Sundrug is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Sundrug? | Sundrug trades under 9989 ticker. |
| When did Sundrug go public? | Sundrug went public in 1997. |
| Who are competitors of Sundrug? | Sundrug main competitors are Fragua, DaShenLin Pharmaceutical, Ebos Group, COSMOS Pharmaceutical. |
| What is the current market cap of Sundrug? | Sundrug's current market cap is $3B. |
| What is the current revenue of Sundrug? | Sundrug's last 12 months revenue is $5B. |
| What is the current revenue growth of Sundrug? | Sundrug revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Sundrug? | Current revenue multiple of Sundrug is 0.5x. |
| Is Sundrug profitable? | Yes, Sundrug is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Sundrug? | Sundrug's last 12 months EBITDA is $419M. |
| What is Sundrug's EBITDA margin? | Sundrug's last 12 months EBITDA margin is 8%. |
| What is the current EV/EBITDA multiple of Sundrug? | Current EBITDA multiple of Sundrug is 6.9x. |
| What is the current FCF of Sundrug? | Sundrug's last 12 months FCF is $71M. |
| What is Sundrug's FCF margin? | Sundrug's last 12 months FCF margin is 1%. |
| What is the current EV/FCF multiple of Sundrug? | Current FCF multiple of Sundrug is 40.6x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.